SGP
SpyGlass Pharma, Inc. Common Stock • NASDAQ
$26.78 ▼ -4.36% (-1.22)
SGP
SpyGlass Pharma, Inc. Common StockNASDAQ • $26.78 ▼ -4.36% (-1.22)
Market Cap $932.89 M
52w High $32.44
52w Low $20.16
P/E -9.17
Volume 25.46K
Outstanding Shares 33.32M
Market Cap $932.89 M
52w High $32.44
52w Low $20.16
P/E -9.17
Volume 25.46K
Outstanding Shares 33.32M
About SpyGlass Pharma, Inc. Common Stock
http://www.spyglasspharma.comSpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions.
CEO
Patrick Mooney
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public January 8, 2008
Method of going public IPO
Full time employees 0
ETFs Holding This Stock
Summary
Total 15
Showing Top 3 of 15
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0